P

Inventor

WU HAN-CHUNG

TW36 patents
⚠️ This page may combine multiple inventors who share the name “WU HAN-CHUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACADEMIA SINICA

15 patents
US10118969B2Nov 6, 2018

Compositions and methods relating to universal glycoforms for enhanced antibody efficacy

ACADEMIA SINICA13 citations84
US10150818B2Dec 11, 2018

Compositions and methods for treatment and detection of cancers

ACADEMIA SINICA10 citations82
US9982041B2May 29, 2018

Compositions and methods for treatment and detection of cancers

ACADEMIA SINICA11 citations82
US9975965B2May 22, 2018

Compositions and methods for treatment and detection of cancers

ACADEMIA SINICA11 citations82
US9387257B2Jul 12, 2016

Lung cancer specific peptides for targeted drug delivery and molecular imaging

ACADEMIA SINICA4 citations65
US11674958B2Jun 13, 2023

Capture, purification, and release of biological substances using a surface coating

ACADEMIA SINICA0 citations60
US9187558B2Nov 17, 2015

Anti-epithelial cell adhesion molecule (EpCAM) antibodies and methods of use thereof

ACADEMIA SINICA2 citations60
US12516107B2Jan 6, 2026

Potent neutralizing antibodies for prevention and treatment of COVID-19

ACADEMIA SINICA0 citations56
US11111276B2Sep 7, 2021

Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

ACADEMIA SINICA1 citations56
US10487120B2Nov 26, 2019

Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

ACADEMIA SINICA1 citations56
US11524978B2Dec 13, 2022

Synthetic peptides, pharmaceutical compositions comprising the same, and uses thereof in treating thromboembolism-related diseases

ACADEMIA SINICA0 citations53
US11357862B2Jun 14, 2022

Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer

ACADEMIA SINICA0 citations53
US12527879B2Jan 20, 2026

Ligands targeted to epidermal growth factor receptors and compositions for use in treating tumors

ACADEMIA SINICA0 citations52
US10196447B2Feb 5, 2019

Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity

ACADEMIA SINICA0 citations43
US8969530B2Mar 3, 2015

Anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof

ACADEMIA SINICA0 citations42

WU HAN-CHUNG

9 patents

UNIV NAT TAIWAN

4 patents

FOUNTAIN BIOPHARMA INC

3 patents

E PIN OPTICAL INDUSTRY CO LTD

1 patent

CHANG YING-CHIH

1 patent

GEORGIA REGENTS RES INST INC

1 patent

CHO PHARMA INC

1 patent

ACEDEMIA SINICA

1 patent